CBIO

Crescent Biopharma

77 hedge funds and large institutions have $567M invested in Crescent Biopharma in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 8177 (-4)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$826K
Puts
$660K
Net Calls
Net Calls Change

Top Sellers

1 -$4.42M
2 -$2.58M
3 -$1.89M
4
Marshall Wace
Marshall Wace
United Kingdom
-$1.5M
5
Citigroup
Citigroup
New York
-$1.29M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$254K
52
$241K
53
$229K
54
$228K
55
$219K
56
$207K
57
$200K
58
$185K
59
$146K
60
$146K
61
$126K
62
$125K
63
$104K
64
$88.3K
65
$83K
66
$76K
67
$47K
68
$37K
69
$31K
70
$25K
71
$18K
72
$12K
73
$6K
74
$5K
75
$3K